Extreme elevation of acute phase reactants and shock secondary to dabrafenib

登录注册会员服务联系我们

Extreme elevation of acute phase reactants and shock secondary to dabrafenib–trametinib

Published:2021-03-18 Issue:3 Volume:31 Page:268-271
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ayala de Miguel Pablo,Gorospe García Itziar,López Gallego Javier,Borrega García Pablo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference11 articles.

1. The pathophysiological basis and consequences of fever.;Walter;Crit Care,2016

2. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.;Long;Ann Oncol,2017

3. Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists.;Atkinson;Asia Pac J Clin Oncol,2016

4. Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.;Vera;Support Care Cancer,2019

5. Dabrafenib and trametinib treatment-associated fevers in metastatic melanoma causing extreme elevation in procalcitonin in the absence of infection.;Clay;Anticancer Drugs,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF‐V600E‐positive non–small cell lung cancer: A case report;Thoracic Cancer;2023-03-19

2. Dabrafenib/trametinib;Reactions Weekly;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP